Eleven Biotherapeutics Secures $20,000,000 Series A Round

  • Feed Type
  • Date
    5/8/2012
  • Company Name
    Eleven Biotherapeutics
  • Mailing Address
    215 First Street Cambridge, MA 02142
  • Company Description
    Eleven Biotherapeutics secured Series A financing in February 2010, backed by two leading life sciences venture capital firms, Flagship Ventures and Third Rock Ventures.
  • Website
    http://www.elevenbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will be used to advance Eleven’s first program, EBI-005, into clinical development while continuing to advance earlier stage programs generated by its proprietary AMP-Rx product engine.
  • M&A Terms
  • Venture Investor
    Jafco Ventures
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Flagship Ventures

By posting a comment, you agree to our terms and conditions.